Skip to content

uMR Jupiter Magnetic Resonance Imaging System Clinical Trial

uMR Jupiter Magnetic Resonance Imaging System Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089988
Enrollment
Unknown
Registered
2024-09-22
Start date
2024-09-22
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Single group (experimental group):Blood biochemical examination Female urine pregnancy test MRI scan User evaluation the device performance Doctors evaluates the image quality Doctors evaluate advance

Sponsors

Qilu Hospital of Shandong University(Qingdao)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years, with the ability to act autonomously; 2. Agree to participate in this clinical trial and sign the informed consent; 3. For using MRI contrast agent, the following inclusion items is added to the above inclusion criteria: Those who clinical trial investigators believe require enhanced magnetic resonance imaging scans.

Exclusion criteria

Exclusion criteria: Any subject meeting any of the following exclusion criteria is excluded: Those with electronic implants, such as cardiac pacemakers, neurostimulators, insulin pumps, cochlear implants, etc.; Those who have undergone aneurysm surgery and have intracranial aneurysm clips; Those who have undergone heart surgery and have artificial heart valves; Those with metallic foreign bodies in the eyes; Those with metallic implants and prostheses, or with metallic foreign bodies in other parts of the body; Pregnant women or those planning to become pregnant within three months, as well as nursing mothers; Critically ill patients requiring life support systems; Patients with epilepsy and mental illness; Patients with claustrophobia; Patients with severe cardiovascular diseases, such as those with heart failure, etc.; Any other conditions deemed unsuitable for participation in this trial by the clinical trial researchers; For subjects undergoing contrast-enhanced magnetic resonance imaging, the following additional exclusion criteria are added to the above subject exclusion criteria: Those with a history of contrast agent allergy, bronchial asthma, or other allergic diseases; Those using beta-blockers; Those with severe renal insufficiency, i.e., eGFR < 30 mL/(min*1.73m^2), using the CKD-EPI calculation formula: eGFR = a * (Scr/b)^c * (0.993)^age.

Design outcomes

Primary

MeasureTime frame
Image quality excellent rate;

Secondary

MeasureTime frame
Stability of device functions;Image quality of advance application functions;

Countries

China

Contacts

Public ContactXiangshui.Meng

Qilu Hospital of Shandong University(Qingdao)

mengxiangshui2021@126.com+86 185 6181 1811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026